Manulife Financial (MFC.TO) Buy, Sell or Hold

Home

Daily Stock Opinions and Ratings

Manulife Financial (MFC.TO)

61.06

+0.02 (0.03%)

as of Aug 12, 2026, 8:00:00 pm Market Open.

1631 watching

Investor Insights

Aug 12, 2026, 12:00 am

This summary was created by AI, based on 27 opinions in the last 12 months.

Manulife Financial (MFC) has shown solid performance recently, particularly in Asia, where it benefits from healthy growth and a stable business in wealth management. However, there is concern over potential government-imposed taxes on its products in mainland China. While the stock has performed well, analysts caution that it is currently feeling somewhat overbought, trading at a price-to-earnings ratio above its historical levels, and advise investors to be selective. Consensus analysis suggests good long-term potential due to its decent dividend yield and solid execution in asset management, even as financial conditions such as interest rates fluctuate. Overall, MFC is viewed as a reliable income stock, with room for growth despite being traded at attractive valuations compared to Canadian banks.

Consensus

Positive

Valuation

Fair Value

Similar

SLF

TOP PICK

John Hancock is a good strategic acquisition/merger. Valuation is very attractive. Stock will remain under pressure for a while.

BUY

The John Hancock acquisition is a good platform for the US. Will take two years to consolidate so may not move very much. Should be a great core holding.

DON'T BUY

Likes the company but would like it at a lower price.

WEAK BUY

Financials are performing quite well. Would prefer Great West life.

BUY

A buying opportunity. Model price is $10/12 higher than the current price. The John Hancock deal was quite cheap.

TOP PICK

Stock is down 10% on the announcement of the John Hancock deal. The deal itself will be 8/10% accretive in the first year. Trading at less than 10 X earnings, which make it a compelling buy.

WAIT

Their acquisition is very good, but the stock will be under some pressure because of the arbitrage and, after the deal closes, expect some US institutional shareholders may not have a mandate to hold Canadian stocks.

TOP PICK

The John Hancock acquisition was great. The weakness in the stock price makes it a good time to buy.

TOP PICK

Has dropped because of their purchase of John Hancock and you are getting it at less than 10 X earnings.

TOP PICK

Likes the acquisition of John Hancock in the US. Extremely well managed company. At a good price.

WAIT

The acquisition of John Hancock was a huge win for the long-term prospects. The stock will probably stall over the next 6 months.

BUY ON WEAKNESS

John Hancock acquisition was bought at a fair price. Synergies seem logical. Good management. US shareholders of John Hancock's will probably sell their shares which could give a real opportunity. Buy in the mid-$30.

BUY

Insurance sector is doing much better than earlier in the year. Looks attractive with their international exposure. Good yield. Solid balance sheet.

BUY

A core holding.

PAST TOP PICK

(Was a top pick June 12/03. Up 10%.) Still likes. Well positioned in their business in both the US and Asia. Disciplined management.

Showing 2,071 to 2,085 of 2,284 entries

Most Recent Experts

Chris Blumas

at Raymond James Investment Counsel Ltd.

Shannon Saccocia, CIO, Boston Private

Boston Private

Joe Terranova

Virtus Investment Partners

Bryn Talkington

Requisite Capital Management

Brian Belski

BMO Capital Markets

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

Manulife Financial (MFC.TO)